Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development

Fig. 6

Effect of epitope glycosylation on MHC class II–epitope 10B binding. Without NAG epitope 10B binding to MHC class II HLA-DRA, DRB epitope binding site (a, b) and different molecular interactions of 10B epitope with MHC class II. c With NAG epitope 10B binding to MHC class II HLA-DRA, DRB epitope binding site (c, d) and different molecular interactions of 10B epitope with MHC class II. f. Lower panel of tabulated image describes amino acids responsible for stable binding between epitope 10B and MHC molecule in presence and absence of NAG

Back to article page